IHI:NYE-iShares U.S. Medical Devices ETF (USD)

ETF | Health |

Last Closing

USD 59.73

Change

-0.58 (-0.96)%

Market Cap

N/A

Volume

0.56M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-21 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

-1.80 (-1.18%)

USD 41.35B
FHLC Fidelity® MSCI Health Care In..

-0.85 (-1.17%)

USD 2.95B
FXH First Trust Health Care AlphaD..

-1.37 (-1.24%)

USD 1.22B
XHE SPDR® S&P Health Care Equipme..

-1.19 (-1.34%)

USD 0.22B
IDNA iShares Genomics Immunology an..

-0.39 (-1.58%)

USD 0.14B
SBIO ALPS Medical Breakthroughs ETF

-0.71 (-1.78%)

USD 0.12B
XHS SPDR® S&P Health Care Service..

-1.52 (-1.58%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

-0.34 (-1.17%)

USD 0.06B
BBP Virtus LifeSci Biotech Product..

-0.76 (-1.20%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

-0.67 (-2.19%)

USD 0.01B

ETFs Containing IHI

ETAC:CA 0.00 % 1.76 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -81.55% 5% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -81.55% 5% F 6% D-
Trailing 12 Months  
Capital Gain -78.39% 10% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -78.39% 10% F 6% D-
Trailing 5 Years  
Capital Gain -75.46% 5% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -75.46% 5% F 10% F
Average Annual (5 Year Horizon)  
Capital Gain 5.30% 43% F 55% F
Dividend Return 5.70% 43% F 49% F
Total Return 0.40% 47% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 21.52% 38% F 49% F
Risk Adjusted Return 26.50% 43% F 44% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.